http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2209555-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
filingDate | 1995-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ecd49605a700f67a76d98067fffee32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108d076a51e2c75d1f7480ff04c8912f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e023a73871103ab2c8751f90f0b7bc09 |
publicationDate | 1996-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2209555-A1 |
titleOfInvention | Tnf-.alpha. inhibitor |
abstract | A method for the propylaxis and treatment of diseases induced by accelerated INF-.alpha. secretion, such as rheumatoid arthritis, endotoxin shock, adult respiratory distress syndrome, thermal burn, asthma, myocardial infarction, acute phase of viral myocardiosis, etc. which comprises administering a carbostyril compound of formula (I) wherein R1 is H or lower alkyl, and R2 is phenyl(lower)alkyl having optionally 1 to 3 lower alkoxy substituents on the phenyl ring, or a pharmaceutically acceptable salt thereof to a subject. |
priorityDate | 1995-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.